272 related articles for article (PubMed ID: 24909847)
21. [Angioneuritic edema in ischaemic stroke patients treated with rt-PA].
Lovász R; Sas A; Kollár T; Petercsák E; Fekete I; Bilinszki E; Valikovics A
Ideggyogy Sz; 2016 Jul; 69(7-8):239-243. PubMed ID: 29465888
[TBL] [Abstract][Full Text] [Related]
22. Hemi-orolingual angioedema and ACE inhibition after alteplase treatment of stroke.
Hill MD; Lye T; Moss H; Barber PA; Demchuk AM; Newcommon NJ; Green TL; Kenney C; Cole-Haskayne A; Buchan AM
Neurology; 2003 May; 60(9):1525-7. PubMed ID: 12743244
[TBL] [Abstract][Full Text] [Related]
23. Influence of on-going treatment with angiotensin-converting enzyme inhibitor or angiotensin receptor blocker on the outcome of patients treated with intravenous rt-PA for ischemic stroke.
Gilliot S; Sibon I; Mas JL; Moulin T; Béjot Y; Cordonnier C; Giroud M; Odou P; Bordet R; Vivien D; Leys D;
J Neurol; 2018 May; 265(5):1166-1173. PubMed ID: 29549467
[TBL] [Abstract][Full Text] [Related]
24. Angioneurotic orolingual oedema following thrombolysis in acute ischaemic stroke.
Wallon D; Girardie P; Bombois S; Lucas C
BMJ Case Rep; 2010 Oct; 2010():. PubMed ID: 22791493
[TBL] [Abstract][Full Text] [Related]
25. Icatibant as a Potential Treatment of Life-Threatening Alteplase-Induced Angioedema.
Cheong E; Dodd L; Smith W; Kleinig T
J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):e36-e37. PubMed ID: 29097062
[TBL] [Abstract][Full Text] [Related]
26. Orolingual angioedema with alteplase administration for treatment of acute ischemic stroke.
Gorski EM; Schmidt MJ
J Emerg Med; 2013 Jul; 45(1):e25-6. PubMed ID: 23664196
[No Abstract] [Full Text] [Related]
27. Select hyperacute complications of ischemic stroke: cerebral edema, hemorrhagic transformation, and orolingual angioedema secondary to intravenous Alteplase.
Bar B; Biller J
Expert Rev Neurother; 2018 Oct; 18(10):749-759. PubMed ID: 30215283
[TBL] [Abstract][Full Text] [Related]
28. Favourable renal outcomes after intravenous thrombolytic therapy for acute ischemic stroke: Clinical implication of kidney-brain axis.
Chang TH; Chiu PF; Tsai CC; Chang CH; Wu CL; Kor CT; Li JR; Kuo CL; Huang CS; Chu CC; Lin CM; Chang CC
Nephrology (Carlton); 2019 Sep; 24(9):896-903. PubMed ID: 30334303
[TBL] [Abstract][Full Text] [Related]
29. [Orolingual angiooedema following intravenous thrombolysis].
Arias-Rivas S; Pardo M; Rodriguez-Yanez M; Lopez-Ferreiro A; Blanco M
Rev Neurol; 2013 Jul; 57(1):46-7. PubMed ID: 23799603
[TBL] [Abstract][Full Text] [Related]
30. Real-World Outcomes of Acute Ischemic Stroke Treatment with Intravenous Recombinant Tissue Plasminogen Activator.
Betts KA; Hurley D; Song J; Sajeev G; Guo J; Du EX; Paschoalin M; Wu EQ
J Stroke Cerebrovasc Dis; 2017 Sep; 26(9):1996-2003. PubMed ID: 28689999
[TBL] [Abstract][Full Text] [Related]
31. A Novel Approach to the Treatment of Orolingual Angioedema After Tissue Plasminogen Activator Administration.
Pahs L; Droege C; Kneale H; Pancioli A
Ann Emerg Med; 2016 Sep; 68(3):345-8. PubMed ID: 27174372
[TBL] [Abstract][Full Text] [Related]
32. Orolingual Angioedema After Tissue Plasminogen Activator Administration in Patients Taking Angiotensin-Converting Enzyme Inhibitors.
Burd M; McPheeters C; Scherrer LA
Adv Emerg Nurs J; 2019; 41(3):204-214. PubMed ID: 31356244
[TBL] [Abstract][Full Text] [Related]
33. Cerebral Microbleeds are an Independent Predictor of Hemorrhagic Transformation Following Intravenous Alteplase Administration in Acute Ischemic Stroke.
Nagaraja N; Tasneem N; Shaban A; Dandapat S; Ahmed U; Policeni B; Olalde H; Shim H; Samaniego EA; Pieper C; Ortega-Gutierrez S; Leira EC; Adams HP
J Stroke Cerebrovasc Dis; 2018 May; 27(5):1403-1411. PubMed ID: 29398533
[TBL] [Abstract][Full Text] [Related]
34. Raising awareness of orolingual angioedema as a complication of thrombolysis in acute stroke patients.
Ottomeyer C; Hennerici MG; Szabo K
Cerebrovasc Dis; 2009; 27(3):307-8. PubMed ID: 19208988
[No Abstract] [Full Text] [Related]
35. Temporal Trends in Clinical Characteristics and Door-to-Needle Time in Patients Receiving Intravenous Tissue Plasminogen Activator: A Retrospective Study of 4 Hospitals in Japan.
Tanaka K; Matsumoto S; Yamada T; Nagano S; Takase KI; Hatano T; Yamasaki R; Kira JI
J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104305. PubMed ID: 31405791
[TBL] [Abstract][Full Text] [Related]
36. Orolingual Angioedema After Tissue Plasminogen Activator Administration in Patients Taking Angiotensin-Converting Enzyme Inhibitors.
Adv Emerg Nurs J; 2019; 41(3):E1-E2. PubMed ID: 31356245
[No Abstract] [Full Text] [Related]
37. Asymmetric oro-facial angioedema following alteplase for acute ischaemic stroke.
Wu TY; Wei DY; Baker Y; Sharkey B; Frith RW
J Clin Neurosci; 2014 Nov; 21(11):2004-6. PubMed ID: 24974191
[TBL] [Abstract][Full Text] [Related]
38. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial.
; Sandercock P; Wardlaw JM; Lindley RI; Dennis M; Cohen G; Murray G; Innes K; Venables G; Czlonkowska A; Kobayashi A; Ricci S; Murray V; Berge E; Slot KB; Hankey GJ; Correia M; Peeters A; Matz K; Lyrer P; Gubitz G; Phillips SJ; Arauz A
Lancet; 2012 Jun; 379(9834):2352-63. PubMed ID: 22632908
[TBL] [Abstract][Full Text] [Related]
39. Fixed Dose IV rt-PA and Clinical Outcome in Ischemic Stroke Patients With Body Weight >100 kg: Pooled Data From 3 Randomized Clinical Trials.
Majidi S; Leon Guerrero CR; Burger KM; Sigounas D; Olan WJ; Qureshi AI
J Stroke Cerebrovasc Dis; 2018 Oct; 27(10):2843-2848. PubMed ID: 30076113
[TBL] [Abstract][Full Text] [Related]
40. TESPI (Thrombolysis in Elderly Stroke Patients in Italy): a randomized controlled trial of alteplase (rt-PA) versus standard treatment in acute ischaemic stroke in patients aged more than 80 years where thrombolysis is initiated within three hours after stroke onset.
Lorenzano S; Toni D;
Int J Stroke; 2012 Apr; 7(3):250-7. PubMed ID: 22292526
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
